drugset / Trial / NCT05082766

Improvement in the Appearance of Periorbital Wrinkles

NCT05082766 ↗

NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to evaluate the efficacy of DefenAge 8-in-1 BioSerum supplemented with the enhanced concentration of defensins (enhanced 8-in-1 BioSerum) in the improvement of periorbital wrinkles.

Timeline

Start
2021-10-11
Primary completion
2022-10-11
Completion
2022-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject enhanced DefenAge 8-in-1 BioSerum Unknown — Topical

Indications

No indication recorded.